Evidence map›Paper›PMID 31944634›Full record

ArticleMolecular genetics & genomic medicine2020

Genetic and clinical analysis in Chinese patients with retinitis pigmentosa caused by EYS mutations.

Yan Sun, Jian-Kang Li, Wei He, Zhuo-Shi Wang, Jin-Yue Bai, Ling Xu, Bo Xing, Jian-Guo Zhang, Lusheng Wang, Wei Li and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. The mutational and clinical spectrum ofFrontiers in genetics · 2026
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Yan SunShenyang He Eye Specialist Hospital, Shenyang, China.
Jian-Kang LiDepartment of Computer Science, City University of Hong Kong, Kowloon, Hong Kong.
Wei HeShenyang He Eye Specialist Hospital, Shenyang, China.
Zhuo-Shi WangShenyang He Eye Specialist Hospital, Shenyang, China.
Jin-Yue BaiSchool of Basic Medicine, Qingdao University, Qingdao, China.
Ling XuShenyang He Eye Specialist Hospital, Shenyang, China.
Bo XingSchool of Basic Medicine, Qingdao University, Qingdao, China.
Jian-Guo ZhangBGI-Shenzhen, Shenzhen, China.
Lusheng WangDepartment of Computer Science, City University of Hong Kong, Kowloon, Hong Kong.
Wei LiHe University, Shenyang, China.
Fang ChenBGI-Shenzhen, Shenzhen, China.ORCID 0000-0001-5993-7912
He University · CNBGI Group (China) · CNQingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPanel-based targeted exome sequencing was applied to identify the pathogenic variants and genetic characteristics of retinitis pigmentosa (RP) in two Chinese families, and to gain a deeper understanding of the relationship between clinical manifestations and genotypes.

methodsA total of 17 subjects, comprising two probands (total patients: four subjects) and their family member, were recruited in this study. All subjects underwent comprehensive ophthalmic examinations and clinical evaluations, and the complete history and medical records were collected according to the standard procedures. All participants were screened using the multigene panel test (Target_Eye_792_V2 chip), and Sanger sequencing was used to confirm the candidate variants.

resultsAmong these two families, a total of three novel mutations in the EYS gene were identified in patients, including a homozygous frameshift mutation c.9252_9253insT detected in two patients in one family, and the compound heterozygous splicesite mutation c.5644+2T>C and frameshift mutation c.1920_1923delTGAG detected in two patients in the another family. All patients in both families had early onset of night blindness and poor visual acuity, and with typical posterior capsule opacification. The mutation co-segregated within all recruited individuals. In addition, one patient with compound heterozygous mutations was found to have typical blue-blindness symptoms and detected a previously reported disease-causing mutation c.235G>A in OPN1SW gene, which caused blue blindness manifestations and was first discovered in patient combined with RP causative genes.

conclusionsPanel-based targeted exome sequencing was used to identify three novel variants of RP causative gene, and we also detected a known pathogenic variants of blue-blindness causative genes in two patients. Our finding will provide a powerful basis for genetic counseling and enhance our current understanding of the genetics factors for RP families.

Indexed as

AdultEye ProteinsFemaleFrameshift MutationHeterozygoteHomozygoteHumansMaleMiddle AgedPedigreePhenotypeRetinitis PigmentosaEye ProteinsEYS protein, humanblue blindnessmutation spectrumpanel-based targeted exome sequencingretinitis pigmentosa

Identifiers

PMID31944634
PMCPMC7057104
OpenAlexW3000008589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.